Company Filing History:
Years Active: 2009-2013
Title: Sonja Sproll: Innovator in Pharmaceutical Chemistry
Introduction
Sonja Sproll is a distinguished inventor based in Munich, Germany. She has made significant contributions to the field of pharmaceutical chemistry, holding 2 patents that reflect her innovative spirit and dedication to advancing medical science.
Latest Patents
Her latest patents include a novel compound, Crystalline ethyl 4-[4-[(2R)-3-[4-amino-3-chloro-5-(trifluoromethyl)phenyl]-1-oxo-2-[[[4-(1,2,4,5-tetrahydro-2-oxo-3H-1,3-benzodiazepin-3-yl)-1-piperidinyl]carbonyl]oxy]propyl]-1-piperazinyl]-piperidine-1-acetate difumarate. This invention relates to new salts of the base with a physiologically acceptable acid, selected from a group that includes hydrochloric acid and fumaric acid, among others. Another patent focuses on new crystalline compounds that are present in the form of their physiologically acceptable salts with various acids, including phosphoric acid and benzenesulphonic acid.
Career Highlights
Sonja Sproll is currently employed at Boehringer Ingelheim International GmbH, where she continues to push the boundaries of pharmaceutical research. Her work has been instrumental in developing new therapeutic compounds that have the potential to improve patient outcomes.
Collaborations
Throughout her career, Sonja has collaborated with notable colleagues, including Uwe Joerg Ries and Ulrike Werthmann. These partnerships have fostered a collaborative environment that enhances innovation and research productivity.
Conclusion
Sonja Sproll's contributions to pharmaceutical chemistry exemplify her commitment to innovation and excellence. Her patents not only highlight her expertise but also pave the way for future advancements in the field.